Andere Kunden interessierten sich auch für
![Surgical Approaches To Facial Skeleton]( "Surgical Approaches To Facial Skeleton")
Surgical Approaches To Facial Skeleton39,99 €![Public health response to COVID-19 pandemic]( "Public health response to COVID-19 pandemic")
Public health response to COVID-19 pandemic29,99 €![Diagnostic and Therapeutic Approaches in Bronchiectasis]( "Diagnostic and Therapeutic Approaches in Bronchiectasis")
Diagnostic and Therapeutic Approaches in Bronchiectasis29,99 €![Hybrid Approaches for Wind Speed Forecasting in India]( "Hybrid Approaches for Wind Speed Forecasting in India")
Hybrid Approaches for Wind Speed Forecasting in India51,99 €![Endoscopic Approaches for Mandibular Condylar Fracture]( "Endoscopic Approaches for Mandibular Condylar Fracture")
Endoscopic Approaches for Mandibular Condylar Fracture29,99 €![Pathogenesis of Pulmonary Fibrosis and New Approaches to the Therapy]( "Pathogenesis of Pulmonary Fibrosis and New Approaches to the Therapy")
Pathogenesis of Pulmonary Fibrosis and New Approaches to the Therapy26,99 €![Medical Image Segmentation Approaches for Identifying Tumor in Brain]( "Medical Image Segmentation Approaches for Identifying Tumor in Brain")
Medical Image Segmentation Approaches for Identifying Tumor in Brain36,99 €
The epidemic of diphtheria at the end of the last century in Eastern Europe recalled the danger of this infection and the urgent need to find ways to prevent its recurrence in the future. A number of questions arose about the deficiencies of the existing immunoprophylaxis of diphtheria, among which the diphtheria incidence of vaccinated persons is of primary importance, the lack of the possibility to influence the level of bacterial carrying and the circulation of the diphtheria causative agents by means of modern diphtheria vaccines, the risk of long-term side effects of vaccination - a toxic effect on the nervous system and triggering an autoimmune processes by means of an adjuvant of aluminum hydroxide in a diphtheria toxoid. The authors of the study suggest to improve the existing diphtheria toxoid vaccine by introducing a diphtheria bacterial antigen component into the vaccine that will activate the innate immunity system in vaccinated individuals, increase colonization resistance to the diphtheria pathogen, stimulate the development of antitoxic immunity, and replace the dangerous chemical adjuvant with aluminum hydroxide, a safer adjuvant of microbial origin.